posted on 2015-12-17, 05:30authored byJianqin Lu, Wenchen Zhao, Yixian Huang, Hao Liu, Rebecca Marquez, Robert
B. Gibbs, Jiang Li, Raman Venkataramanan, Liang Xu, Shulin Li, Song Li
Doxorubicin
(DOX) is one of the most commonly used antineoplastic
agents, but its clinical application is oftentimes coupled with severe
side effects. Selective delivery of DOX to tumors via nanosized drug
carrier represents an attractive approach to this problem. Previously,
we developed a dual functional nanomicellar carrier, PEG5K-embelin2 (PEG5K-EB2), which was
able to deliver paclitaxel (PTX) selectively to tumors and to achieve
an enhanced therapeutic effect. In the present study, we examined
the utility of PEG5K-EB2 to deliver DOX to tumors.
In addition, folic acid (FA) was coupled to the surface of the PEG5K-EB2 micelles (FA-PEG5K-EB2) to further improve the selective targetability of the system. DOX-loaded
PEG5K-EB2 micelles were uniformly spherical
particles with a diameter of approximately 20 nm. Incorporation of
FA had minimal effect on the size of the particles. The DOX loading
efficiency was as high as 91.7% and 93.5% for PEG5K-EB2 and FA-PEG5K-EB2, respectively. DOX
formulated in PEG5K-EB2 micelles (with or without
FA decoration) demonstrated sustained kinetics of DOX release compared
to free DOX. FA-PEG5K-EB2 significantly facilitated
the intracellular uptake of DOX over free DOX and PEGylated liposomal
DOX (Doxil) in breast cancer cells, 4T1.2, and drug resistant cells,
NCI/ADR-RES. P-gp ATPase assay showed that PEG5K-EB2 significantly inhibited the function of the P-gp efflux pump.
The maximum tolerated dose of DOX-loaded PEG5K-EB2 micelles was 15 mg/kg in mice, which was 1.5-fold greater than that
for free DOX. Pharmacokinetics (PK) and biodistribution studies showed
that both types of DOX-loaded micelles, especially FA-PEG5K-EB2, were able to significantly prolong the blood circulation
time of DOX and facilitate its preferential accumulation at the tumor
tissue. Finally, DOX/PEG5K-EB2 mixed micelles
demonstrated significantly enhanced tumor growth inhibitory effect
with minimal toxicity in comparison to free DOX and Doxil and the
antitumor activity was further enhanced after the decoration by folic
acid. Our data suggest that FA-PEG5K-EB2 micelles
represent a promising DOX delivery system that warrants more study
in the future.